주식/증권 📈 긍정적

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Yahoo Finance 2026/06/05 18:11:00 9회

요약

Glaukos is riding strong on iDose TR growth and launching Epioxa into a large underpenetrated market, but reimbursement and competition risks persist.

원문 기사 보기

관련 뉴스

My son passed away. Am I crazy to move to my former home and sell a house I bought in September?

2026/06/25

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

2026/06/25

WISeKey, SEALSQ set up Quantisimo SPV for $575M merger deal

2026/06/25

Conagra (CAG) Launches 100 Brand Products As It Moves From S&P 500

2026/06/25

뉴스 목록으로